Open28.000 | Close28.270 |
Vol / Avg.1.186M / 1.047M | Mkt Cap2.032B |
Day Range27.730 - 28.480 | 52 Wk Range15.870 - 59.240 |
Schrodinger Stock (NASDAQ: SDGR) stock price, news, charts, stock research, profile.
Open28.000 | Close28.270 |
Vol / Avg.1.186M / 1.047M | Mkt Cap2.032B |
Day Range27.730 - 28.480 | 52 Wk Range15.870 - 59.240 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.410 | -0.790 | -0.3800 | ||||
REV | 33.010M | 35.189M | 2.179M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-04 | Morgan Stanley | Vikram Malhorta | Reiterates | Equal-WeightEqual-Weight | Maintains | 52.00 | 52.00 |
2023-08-03 | BMO Capital | Gary Nachman | Maintains | OutperformOutperform | Lowers | 78.00 | 67.00 |
2023-06-29 | Morgan Stanley | Vikram Malhorta | Maintains | Equal-WeightEqual-Weight | Raises | 38.00 | 52.00 |
2023-05-08 | Citigroup | David Lebowitz | Maintains | Buy | Lowers | 52.00 | 50.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
SDGR | Schrodinger | 3.25% | 2B |
MPLN | MultiPlan | 3.07% | 1.1B |
OPRX | OptimizeRx | 1.04% | 129.4M |
GDRX | GoodRx Holdings | 2.17% | 2.2B |
DH | Definitive Healthcare | -0.12% | 905.3M |
You can purchase shares of Schrodinger (NASDAQ: SDGR) through any online brokerage.
Other companies in Schrodinger’s space includes: MultiPlan (NYSE:MPLN), OptimizeRx (NASDAQ:OPRX), GoodRx Holdings (NASDAQ:GDRX), Definitive Healthcare (NASDAQ:DH) and Veeva Sys (NYSE:VEEV).
The latest price target for Schrodinger (NASDAQ: SDGR) was reported by Morgan Stanley on Friday, August 4, 2023. The analyst firm set a price target for 52.00 expecting SDGR to rise to within 12 months (a possible 83.94% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Schrodinger (NASDAQ: SDGR) is $28.27 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Schrodinger.
Schrodinger’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Schrodinger.
Schrodinger is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Schrodinger Stock (NASDAQ: SDGR) stock price, news, charts, stock research, profile.
Open28.000 | Close28.270 |
Vol / Avg.1.186M / 1.047M | Mkt Cap2.032B |
Day Range27.730 - 28.480 | 52 Wk Range15.870 - 59.240 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.410 | -0.790 | -0.3800 | ||||
REV | 33.010M | 35.189M | 2.179M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-04 | Morgan Stanley | Vikram Malhorta | Reiterates | Equal-WeightEqual-Weight | Maintains | 52.00 | 52.00 |
2023-08-03 | BMO Capital | Gary Nachman | Maintains | OutperformOutperform | Lowers | 78.00 | 67.00 |
2023-06-29 | Morgan Stanley | Vikram Malhorta | Maintains | Equal-WeightEqual-Weight | Raises | 38.00 | 52.00 |
2023-05-08 | Citigroup | David Lebowitz | Maintains | Buy | Lowers | 52.00 | 50.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
SDGR | Schrodinger | 3.25% | 2B |
MPLN | MultiPlan | 3.07% | 1.1B |
OPRX | OptimizeRx | 1.04% | 129.4M |
GDRX | GoodRx Holdings | 2.17% | 2.2B |
DH | Definitive Healthcare | -0.12% | 905.3M |
You can purchase shares of Schrodinger (NASDAQ: SDGR) through any online brokerage.
Other companies in Schrodinger’s space includes: MultiPlan (NYSE:MPLN), OptimizeRx (NASDAQ:OPRX), GoodRx Holdings (NASDAQ:GDRX), Definitive Healthcare (NASDAQ:DH) and Veeva Sys (NYSE:VEEV).
The latest price target for Schrodinger (NASDAQ: SDGR) was reported by Morgan Stanley on Friday, August 4, 2023. The analyst firm set a price target for 52.00 expecting SDGR to rise to within 12 months (a possible 83.94% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Schrodinger (NASDAQ: SDGR) is $28.27 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Schrodinger.
Schrodinger’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Schrodinger.
Schrodinger is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Schrodinger Stock (NASDAQ: SDGR) stock price, news, charts, stock research, profile.
Open28.000 | Close28.270 |
Vol / Avg.1.186M / 1.047M | Mkt Cap2.032B |
Day Range27.730 - 28.480 | 52 Wk Range15.870 - 59.240 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.410 | -0.790 | -0.3800 | ||||
REV | 33.010M | 35.189M | 2.179M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-04 | Morgan Stanley | Vikram Malhorta | Reiterates | Equal-WeightEqual-Weight | Maintains | 52.00 | 52.00 |
2023-08-03 | BMO Capital | Gary Nachman | Maintains | OutperformOutperform | Lowers | 78.00 | 67.00 |
2023-06-29 | Morgan Stanley | Vikram Malhorta | Maintains | Equal-WeightEqual-Weight | Raises | 38.00 | 52.00 |
2023-05-08 | Citigroup | David Lebowitz | Maintains | Buy | Lowers | 52.00 | 50.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
SDGR | Schrodinger | 3.25% | 2B |
MPLN | MultiPlan | 3.07% | 1.1B |
OPRX | OptimizeRx | 1.04% | 129.4M |
GDRX | GoodRx Holdings | 2.17% | 2.2B |
DH | Definitive Healthcare | -0.12% | 905.3M |
You can purchase shares of Schrodinger (NASDAQ: SDGR) through any online brokerage.
Other companies in Schrodinger’s space includes: MultiPlan (NYSE:MPLN), OptimizeRx (NASDAQ:OPRX), GoodRx Holdings (NASDAQ:GDRX), Definitive Healthcare (NASDAQ:DH) and Veeva Sys (NYSE:VEEV).
The latest price target for Schrodinger (NASDAQ: SDGR) was reported by Morgan Stanley on Friday, August 4, 2023. The analyst firm set a price target for 52.00 expecting SDGR to rise to within 12 months (a possible 83.94% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Schrodinger (NASDAQ: SDGR) is $28.27 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Schrodinger.
Schrodinger’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Schrodinger.
Schrodinger is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Schrodinger Stock (NASDAQ: SDGR) stock price, news, charts, stock research, profile.
Open28.000 | Close28.270 |
Vol / Avg.1.186M / 1.047M | Mkt Cap2.032B |
Day Range27.730 - 28.480 | 52 Wk Range15.870 - 59.240 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.410 | -0.790 | -0.3800 | ||||
REV | 33.010M | 35.189M | 2.179M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-04 | Morgan Stanley | Vikram Malhorta | Reiterates | Equal-WeightEqual-Weight | Maintains | 52.00 | 52.00 |
2023-08-03 | BMO Capital | Gary Nachman | Maintains | OutperformOutperform | Lowers | 78.00 | 67.00 |
2023-06-29 | Morgan Stanley | Vikram Malhorta | Maintains | Equal-WeightEqual-Weight | Raises | 38.00 | 52.00 |
2023-05-08 | Citigroup | David Lebowitz | Maintains | Buy | Lowers | 52.00 | 50.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
SDGR | Schrodinger | 3.25% | 2B |
MPLN | MultiPlan | 3.07% | 1.1B |
OPRX | OptimizeRx | 1.04% | 129.4M |
GDRX | GoodRx Holdings | 2.17% | 2.2B |
DH | Definitive Healthcare | -0.12% | 905.3M |
You can purchase shares of Schrodinger (NASDAQ: SDGR) through any online brokerage.
Other companies in Schrodinger’s space includes: MultiPlan (NYSE:MPLN), OptimizeRx (NASDAQ:OPRX), GoodRx Holdings (NASDAQ:GDRX), Definitive Healthcare (NASDAQ:DH) and Veeva Sys (NYSE:VEEV).
The latest price target for Schrodinger (NASDAQ: SDGR) was reported by Morgan Stanley on Friday, August 4, 2023. The analyst firm set a price target for 52.00 expecting SDGR to rise to within 12 months (a possible 83.94% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Schrodinger (NASDAQ: SDGR) is $28.27 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Schrodinger.
Schrodinger’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Schrodinger.
Schrodinger is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Schrodinger Stock (NASDAQ: SDGR) stock price, news, charts, stock research, profile.
Open28.000 | Close28.270 |
Vol / Avg.1.186M / 1.047M | Mkt Cap2.032B |
Day Range27.730 - 28.480 | 52 Wk Range15.870 - 59.240 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.410 | -0.790 | -0.3800 | ||||
REV | 33.010M | 35.189M | 2.179M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-04 | Morgan Stanley | Vikram Malhorta | Reiterates | Equal-WeightEqual-Weight | Maintains | 52.00 | 52.00 |
2023-08-03 | BMO Capital | Gary Nachman | Maintains | OutperformOutperform | Lowers | 78.00 | 67.00 |
2023-06-29 | Morgan Stanley | Vikram Malhorta | Maintains | Equal-WeightEqual-Weight | Raises | 38.00 | 52.00 |
2023-05-08 | Citigroup | David Lebowitz | Maintains | Buy | Lowers | 52.00 | 50.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
SDGR | Schrodinger | 3.25% | 2B |
MPLN | MultiPlan | 3.07% | 1.1B |
OPRX | OptimizeRx | 1.04% | 129.4M |
GDRX | GoodRx Holdings | 2.17% | 2.2B |
DH | Definitive Healthcare | -0.12% | 905.3M |
You can purchase shares of Schrodinger (NASDAQ: SDGR) through any online brokerage.
Other companies in Schrodinger’s space includes: MultiPlan (NYSE:MPLN), OptimizeRx (NASDAQ:OPRX), GoodRx Holdings (NASDAQ:GDRX), Definitive Healthcare (NASDAQ:DH) and Veeva Sys (NYSE:VEEV).
The latest price target for Schrodinger (NASDAQ: SDGR) was reported by Morgan Stanley on Friday, August 4, 2023. The analyst firm set a price target for 52.00 expecting SDGR to rise to within 12 months (a possible 83.94% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Schrodinger (NASDAQ: SDGR) is $28.27 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Schrodinger.
Schrodinger’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Schrodinger.
Schrodinger is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Schrodinger Stock (NASDAQ: SDGR) stock price, news, charts, stock research, profile.
Open28.000 | Close28.270 |
Vol / Avg.1.186M / 1.047M | Mkt Cap2.032B |
Day Range27.730 - 28.480 | 52 Wk Range15.870 - 59.240 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.410 | -0.790 | -0.3800 | ||||
REV | 33.010M | 35.189M | 2.179M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-04 | Morgan Stanley | Vikram Malhorta | Reiterates | Equal-WeightEqual-Weight | Maintains | 52.00 | 52.00 |
2023-08-03 | BMO Capital | Gary Nachman | Maintains | OutperformOutperform | Lowers | 78.00 | 67.00 |
2023-06-29 | Morgan Stanley | Vikram Malhorta | Maintains | Equal-WeightEqual-Weight | Raises | 38.00 | 52.00 |
2023-05-08 | Citigroup | David Lebowitz | Maintains | Buy | Lowers | 52.00 | 50.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
SDGR | Schrodinger | 3.25% | 2B |
MPLN | MultiPlan | 3.07% | 1.1B |
OPRX | OptimizeRx | 1.04% | 129.4M |
GDRX | GoodRx Holdings | 2.17% | 2.2B |
DH | Definitive Healthcare | -0.12% | 905.3M |
You can purchase shares of Schrodinger (NASDAQ: SDGR) through any online brokerage.
Other companies in Schrodinger’s space includes: MultiPlan (NYSE:MPLN), OptimizeRx (NASDAQ:OPRX), GoodRx Holdings (NASDAQ:GDRX), Definitive Healthcare (NASDAQ:DH) and Veeva Sys (NYSE:VEEV).
The latest price target for Schrodinger (NASDAQ: SDGR) was reported by Morgan Stanley on Friday, August 4, 2023. The analyst firm set a price target for 52.00 expecting SDGR to rise to within 12 months (a possible 83.94% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Schrodinger (NASDAQ: SDGR) is $28.27 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Schrodinger.
Schrodinger’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Schrodinger.
Schrodinger is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Schrodinger Stock (NASDAQ: SDGR) stock price, news, charts, stock research, profile.
Open28.000 | Close28.270 |
Vol / Avg.1.186M / 1.047M | Mkt Cap2.032B |
Day Range27.730 - 28.480 | 52 Wk Range15.870 - 59.240 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.410 | -0.790 | -0.3800 | ||||
REV | 33.010M | 35.189M | 2.179M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-04 | Morgan Stanley | Vikram Malhorta | Reiterates | Equal-WeightEqual-Weight | Maintains | 52.00 | 52.00 |
2023-08-03 | BMO Capital | Gary Nachman | Maintains | OutperformOutperform | Lowers | 78.00 | 67.00 |
2023-06-29 | Morgan Stanley | Vikram Malhorta | Maintains | Equal-WeightEqual-Weight | Raises | 38.00 | 52.00 |
2023-05-08 | Citigroup | David Lebowitz | Maintains | Buy | Lowers | 52.00 | 50.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
SDGR | Schrodinger | 3.25% | 2B |
MPLN | MultiPlan | 3.07% | 1.1B |
OPRX | OptimizeRx | 1.04% | 129.4M |
GDRX | GoodRx Holdings | 2.17% | 2.2B |
DH | Definitive Healthcare | -0.12% | 905.3M |
You can purchase shares of Schrodinger (NASDAQ: SDGR) through any online brokerage.
Other companies in Schrodinger’s space includes: MultiPlan (NYSE:MPLN), OptimizeRx (NASDAQ:OPRX), GoodRx Holdings (NASDAQ:GDRX), Definitive Healthcare (NASDAQ:DH) and Veeva Sys (NYSE:VEEV).
The latest price target for Schrodinger (NASDAQ: SDGR) was reported by Morgan Stanley on Friday, August 4, 2023. The analyst firm set a price target for 52.00 expecting SDGR to rise to within 12 months (a possible 83.94% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Schrodinger (NASDAQ: SDGR) is $28.27 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Schrodinger.
Schrodinger’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Schrodinger.
Schrodinger is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Schrodinger Stock (NASDAQ: SDGR) stock price, news, charts, stock research, profile.
Open28.000 | Close28.270 |
Vol / Avg.1.186M / 1.047M | Mkt Cap2.032B |
Day Range27.730 - 28.480 | 52 Wk Range15.870 - 59.240 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.410 | -0.790 | -0.3800 | ||||
REV | 33.010M | 35.189M | 2.179M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-04 | Morgan Stanley | Vikram Malhorta | Reiterates | Equal-WeightEqual-Weight | Maintains | 52.00 | 52.00 |
2023-08-03 | BMO Capital | Gary Nachman | Maintains | OutperformOutperform | Lowers | 78.00 | 67.00 |
2023-06-29 | Morgan Stanley | Vikram Malhorta | Maintains | Equal-WeightEqual-Weight | Raises | 38.00 | 52.00 |
2023-05-08 | Citigroup | David Lebowitz | Maintains | Buy | Lowers | 52.00 | 50.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
SDGR | Schrodinger | 3.25% | 2B |
MPLN | MultiPlan | 3.07% | 1.1B |
OPRX | OptimizeRx | 1.04% | 129.4M |
GDRX | GoodRx Holdings | 2.17% | 2.2B |
DH | Definitive Healthcare | -0.12% | 905.3M |
You can purchase shares of Schrodinger (NASDAQ: SDGR) through any online brokerage.
Other companies in Schrodinger’s space includes: MultiPlan (NYSE:MPLN), OptimizeRx (NASDAQ:OPRX), GoodRx Holdings (NASDAQ:GDRX), Definitive Healthcare (NASDAQ:DH) and Veeva Sys (NYSE:VEEV).
The latest price target for Schrodinger (NASDAQ: SDGR) was reported by Morgan Stanley on Friday, August 4, 2023. The analyst firm set a price target for 52.00 expecting SDGR to rise to within 12 months (a possible 83.94% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Schrodinger (NASDAQ: SDGR) is $28.27 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Schrodinger.
Schrodinger’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Schrodinger.
Schrodinger is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.
Schrodinger Stock (NASDAQ: SDGR) stock price, news, charts, stock research, profile.
Open28.000 | Close28.270 |
Vol / Avg.1.186M / 1.047M | Mkt Cap2.032B |
Day Range27.730 - 28.480 | 52 Wk Range15.870 - 59.240 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.410 | -0.790 | -0.3800 | ||||
REV | 33.010M | 35.189M | 2.179M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-08-04 | Morgan Stanley | Vikram Malhorta | Reiterates | Equal-WeightEqual-Weight | Maintains | 52.00 | 52.00 |
2023-08-03 | BMO Capital | Gary Nachman | Maintains | OutperformOutperform | Lowers | 78.00 | 67.00 |
2023-06-29 | Morgan Stanley | Vikram Malhorta | Maintains | Equal-WeightEqual-Weight | Raises | 38.00 | 52.00 |
2023-05-08 | Citigroup | David Lebowitz | Maintains | Buy | Lowers | 52.00 | 50.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
SDGR | Schrodinger | 3.25% | 2B |
MPLN | MultiPlan | 3.07% | 1.1B |
OPRX | OptimizeRx | 1.04% | 129.4M |
GDRX | GoodRx Holdings | 2.17% | 2.2B |
DH | Definitive Healthcare | -0.12% | 905.3M |
You can purchase shares of Schrodinger (NASDAQ: SDGR) through any online brokerage.
Other companies in Schrodinger’s space includes: MultiPlan (NYSE:MPLN), OptimizeRx (NASDAQ:OPRX), GoodRx Holdings (NASDAQ:GDRX), Definitive Healthcare (NASDAQ:DH) and Veeva Sys (NYSE:VEEV).
The latest price target for Schrodinger (NASDAQ: SDGR) was reported by Morgan Stanley on Friday, August 4, 2023. The analyst firm set a price target for 52.00 expecting SDGR to rise to within 12 months (a possible 83.94% upside). 11 analyst firms have reported ratings in the last year.
The stock price for Schrodinger (NASDAQ: SDGR) is $28.27 last updated September 29, 2023 at 8:00 PM UTC.
There is no dividend information for Schrodinger.
Schrodinger’s Q3 earnings are confirmed for Thursday, November 2, 2023.
There is no upcoming split for Schrodinger.
Schrodinger is in the Health Care sector and Health Care Technology industry. They are listed on the NASDAQ.